PolyNovo Limited
PolyNovo Limited (CALZF) Revenue
Annual & quarterly revenue history · segment & region breakdown
CALZF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsPolyNovo Limited trailing twelve-month (TTM) revenue is $0.25B, an increase of 23.31% year-over-year from $0.13B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-06-30 | $0.13B | +$0.02B | +23.31% |
| 2024-06-30 | $0.10B | +$0.04B | +58.17% |
| 2023-06-30 | $0.07B | +$0.02B | +57.43% |
| 2022-06-30 | $0.04B | +$0.01B | +42.12% |
| 2021-06-30 | $0.03B | +$0.01B | +31.60% |
| 2020-06-30 | $0.02B | +$0.01B | +57.76% |
| 2019-06-30 | $0.01B | +$0.01B | +114.28% |
| 2018-06-30 | $0.01B | +$0.00B | +81.05% |
| 2017-06-30 | $0.00B | +$0.00B | +10.47% |
| 2016-06-30 | $0.00B | +$0.00B | +14569.41% |
Compare revenue vs peers
Medical - DevicesCompare CALZF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income PolyNovo Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
PolyNovo Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in AUD.
Data sourced from PolyNovo Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CALZF revenue · 4 questionsCALZF's trailing twelve-month (TTM) revenue is $0.25B. That is an increase of 23.31% year-over-year from $0.13B in FY2025.
▸ Source: FMP · PolyNovo Limited SEC filings · GAAP · PolyNovo Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026